Eli Lilly’s Oral GLP-1 Approved, SpaceX Confidentially Files for IPO, Potential Activist Targets 4/1/26

Breaking this hour… Eli Lilly’s oral weight-loss pill approved by the FDA. What the company’s CEO told CNBC about the growth story. Then new reports say SpaceX has confidentially filed for an IPO. Plus, which companies could be the next target of an activist investor? Barclays with a new report looking at just that. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Apr 1, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Eli Lilly’s Oral GLP-1 Approved, SpaceX Confidentially Files for IPO, Potential Activist Targets 4/1/26

0:00 43:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Rich and Spiritual Anuja Patil : Wealth & Womanhood Mentor Podcast for Creative & Spiritual Female Leaders. Liberate your stories around money and spirituality. Master a language of money through sensuality & spirituality so your soul-led business thrives and flourishes.

Frequently Asked Questions

How long is this episode of CNBC’s “Money Movers”?

This episode is 43 minutes long.

When was this CNBC’s “Money Movers” episode published?

This episode was published on April 1, 2026.

Can I download this CNBC’s “Money Movers” episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!